rs1060500754

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_020975.6(RET):​c.650C>A​(p.Ala217Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000141 in 1,423,298 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A217V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

RET
NM_020975.6 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 0.392

Publications

1 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07448417).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020975.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
NM_020975.6
MANE Select
c.650C>Ap.Ala217Asp
missense
Exon 4 of 20NP_066124.1
RET
NM_001406743.1
c.650C>Ap.Ala217Asp
missense
Exon 4 of 21NP_001393672.1
RET
NM_001406744.1
c.650C>Ap.Ala217Asp
missense
Exon 4 of 20NP_001393673.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
ENST00000355710.8
TSL:5 MANE Select
c.650C>Ap.Ala217Asp
missense
Exon 4 of 20ENSP00000347942.3
RET
ENST00000340058.6
TSL:1
c.650C>Ap.Ala217Asp
missense
Exon 4 of 19ENSP00000344798.4
RET
ENST00000713926.1
c.521C>Ap.Ala174Asp
missense
Exon 4 of 19ENSP00000519223.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000141
AC:
2
AN:
1423298
Hom.:
0
Cov.:
36
AF XY:
0.00000142
AC XY:
1
AN XY:
706254
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33078
American (AMR)
AF:
0.00
AC:
0
AN:
40444
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25566
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38454
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82644
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38948
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4360
European-Non Finnish (NFE)
AF:
9.09e-7
AC:
1
AN:
1100554
Other (OTH)
AF:
0.0000169
AC:
1
AN:
59250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Multiple endocrine neoplasia, type 2 (2)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
1
-
Multiple endocrine neoplasia type 2A;C0025269:Multiple endocrine neoplasia type 2B;C0031511:Pheochromocytoma;C1833921:Familial medullary thyroid carcinoma;C3888239:Hirschsprung disease, susceptibility to, 1 (1)
-
1
-
not provided (1)
-
1
-
RET-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
14
DANN
Benign
0.90
DEOGEN2
Benign
0.30
T
Eigen
Benign
-0.98
Eigen_PC
Benign
-0.94
FATHMM_MKL
Benign
0.0091
N
LIST_S2
Benign
0.57
T
M_CAP
Benign
0.038
D
MetaRNN
Benign
0.074
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.57
N
PhyloP100
0.39
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.88
N
REVEL
Benign
0.16
Sift
Benign
0.18
T
Sift4G
Benign
0.66
T
Polyphen
0.0
B
Vest4
0.18
MutPred
0.54
Gain of disorder (P = 0.056)
MVP
0.16
MPC
1.1
ClinPred
0.065
T
GERP RS
-1.3
Varity_R
0.11
gMVP
0.62
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060500754; hg19: chr10-43600424; API